Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible
In Brief: Gallo Signs Agreement With Univ. of Maryland; Donor Gives $5 Million To San Diego Center
Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study
DCPC Advisors Okay New Grant Programs To Improve Participation Of Women, Minorities In Clinical Trials
National Action Plan Issues Complete List Of Breast Cancer Funding Mechanisms
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









